Patents by Inventor Qiang Cheng

Qiang Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11766408
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: September 26, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Qiang Cheng, Tuo Wei, Daniel J. Siegwart
  • Publication number: 20230300886
    Abstract: A method can include determining candidate sidelink resources by a user equipment (UE) for sidelink transmission on an unlicensed band from a sidelink resource selection window based on results of a sensing operation on the unlicensed band during a sidelink sensing window, selecting a sidelink resource from the candidate sidelink resources, performing a listen-before-talk (LBT) process on the unlicensed band to obtain a channel occupancy time (COT), and performing a sidelink transmission within the COT using the first sidelink resource. The selection of the sidelink resource can be based on an LBT time that is a predicted duration of a random backoff process of the first LBT process. Also, the first sidelink resource can be selected from the candidate sidelink resources without randomization.
    Type: Application
    Filed: March 8, 2023
    Publication date: September 21, 2023
    Applicant: MEDIATEK INC.
    Inventors: Jing-Wei CHEN, Tao CHEN, Lung-Sheng TSAI, Jun-Qiang CHENG, Yih-Shen CHEN
  • Publication number: 20230300885
    Abstract: A method can include determining candidate sidelink resources by a user equipment (UE) for sidelink transmission on an unlicensed band from a sidelink resource selection window based on results of a sensing operation on the unlicensed band during a sidelink sensing window, selecting a sidelink resource from the candidate sidelink resources, performing a listen-before-talk (LBT) process on the unlicensed band to obtain a channel occupancy time (COT), and performing a sidelink transmission within the COT using the first sidelink resource. The selection of the sidelink resource can be based on an LBT time that is a predicted duration of a random backoff process of the first LBT process. Also, the first sidelink resource can be selected from the candidate sidelink resources without randomization.
    Type: Application
    Filed: March 8, 2023
    Publication date: September 21, 2023
    Applicant: MEDIATEK INC.
    Inventors: Jing-Wei CHEN, Tao CHEN, Lung-Sheng TSAI, Jun-Qiang CHENG, Yih-Shen CHEN
  • Publication number: 20230254898
    Abstract: Apparatus and methods are provided for sidelink resource selection in unlicensed frequency bands. In one novel aspect, a combination of SL resource selection procedure and a listen-before-talk (LBT) procedure are used for resource selection in unlicensed frequency bands. In one embodiment, the LBT procedure is performed after the SL resource selection procedure. In one embodiment, the candidate resource selected by the SL resource selection procedure has an overbooking resource size larger than or equal to a resource size required for the SL data transceiving. In another embodiment, the overbooking resource size is dynamically determined based on one or more preconfigured conditions comprising an LBT failure probability, channel loading status information, and channel congestion control information. In yet another embodiment, the candidate resources are multi-consecutive-slot (MCSt) resources with configured multiple consecutive resource blocks.
    Type: Application
    Filed: February 7, 2023
    Publication date: August 10, 2023
    Inventors: Jun-Qiang Cheng, Tao Chen, Min Lei
  • Publication number: 20230243849
    Abstract: Tools for identifying risk of cerebral edema in a stroke patient are provided and include a method that involves identifying risk of cerebral edema when cytokines and chemokines are detected in a systemic blood sample from the subject.
    Type: Application
    Filed: May 26, 2021
    Publication date: August 3, 2023
    Inventors: Keith R. Pennypacker, Justin F. Fraser, Qiang Cheng
  • Publication number: 20230178100
    Abstract: Provided are a tail point detection method and apparatus, a device, and a storage medium. The implementation scheme includes acquiring a target audio; identifying a sentence pattern type of the target audio; determining detection waiting duration according to the sentence pattern type; and determining a result of detecting a tail point of the target audio according to the detection waiting duration.
    Type: Application
    Filed: December 5, 2022
    Publication date: June 8, 2023
    Inventors: Chunming DU, Yongle WANG, Lifeng ZHAO, Dan WANG, Qiang CHENG, Mushui XU, Pengwei LI
  • Patent number: 11660120
    Abstract: A visualized surgical assembly is provided, characterized in that the visualized surgical assembly includes a disposable drainage tube and a functional tube for providing visualization function, the disposable drainage tube and the functional tube are connected detachable along the axial of the tube body, and the functional tube is provided with a self-destructive part for cutting the disposable drainage tube. A corresponding endoscope is also provided. The visualized surgical assembly is a combination structure of the disposable drainage tube and the functional tube which can provide visualization function. The disposable drainage tube can removable connect with the functional tube, and the functional tube can be repeated disinfection, which can reduce the cost and avoid the risk of cross infection.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: May 30, 2023
    Assignee: SHANGHAI OUTAI MEDICAL EQUIPMENT CO., LTD.
    Inventors: Rui Xu, Suping Liu, Zhujun Tang, Tong Zhao, Lei Cen, Yungui Liu, Xukai Wang, Qiang Cheng
  • Patent number: 11648210
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Grant
    Filed: September 4, 2022
    Date of Patent: May 16, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Qiang Cheng, Tuo Wei, Daniel J. Siegwart
  • Patent number: 11648209
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: May 16, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Qiang Cheng, Tuo Wei, Daniel J. Siegwart
  • Publication number: 20230134886
    Abstract: The presently-disclosed subject matter generally to methods for identifying and analyzing biomarkers to determine group effects. The presently-disclosed subject matter also relates to methods for identifying genes and proteins that increase or decrease in response to ischemic stroke damage. The disclosed subject matter further describes methods of predicting edema and infarct volume in a patient. Also described herein are methods of determining the necessity of intervention for smokers. Further disclosed herein, are methods for testing therapies for ischemic stroke.
    Type: Application
    Filed: October 13, 2020
    Publication date: May 4, 2023
    Inventors: Keith R. Pennypacker, Justin F. Fraser, Qiang Cheng
  • Patent number: 11590085
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: February 28, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Qiang Cheng, Tuo Wei, Daniel J. Siegwart
  • Publication number: 20230026843
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Application
    Filed: September 4, 2022
    Publication date: January 26, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Qiang CHENG, Tuo WEI, Daniel J. SIEGWART
  • Publication number: 20220387337
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Application
    Filed: June 14, 2022
    Publication date: December 8, 2022
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Qiang CHENG, Tuo WEI, Daniel J. SIEGWART
  • Patent number: 11510880
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: November 29, 2022
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Qiang Cheng, Tuo Wei, Daniel J. Siegwart
  • Publication number: 20220325255
    Abstract: Embodiments of the instant disclosure relate to novel antiviral compositions and methods for treating viral infections. In accordance with these embodiments, antiviral compositions can include at least one mRNA encoding for a TRIM7 protein encapsulated into a lipid nanoparticle (LNP). In other embodiments, methods of making antiviral compositions are disclosed as well as methods of administering a composition having at least one mRNA encoding for a TRIM7 protein encapsulated into LNP into a subject.
    Type: Application
    Filed: March 31, 2022
    Publication date: October 13, 2022
    Inventors: John W. Schoggins, Wenchun Fan, Daniel J. Siegwart, Qiang Cheng
  • Publication number: 20220318356
    Abstract: The present disclosure relates to the technical field of Internet, and provides a user registration method, a user login method and a device corresponding thereto. In these methods, a passport or the user card records identity information of the autonomous identity of a user, and the user can use the passport or the user card to access an application website, which is unlike the conventional method of performing the accessing through the account and the password. Moreover, the present disclosure further implements a series of mechanisms from the application to the use, concerning the passport and the user card.
    Type: Application
    Filed: April 13, 2022
    Publication date: October 6, 2022
    Inventor: Qiang CHENG
  • Publication number: 20220233460
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Application
    Filed: April 1, 2022
    Publication date: July 28, 2022
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Qiang CHENG, Tuo WEI, Daniel J. SIEGWART
  • Publication number: 20220133637
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Application
    Filed: January 10, 2022
    Publication date: May 5, 2022
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Qiang CHENG, Tuo WEI, Daniel J. SIEGWART
  • Publication number: 20220117631
    Abstract: A visualized surgical assembly is provided, characterized in that the visualized surgical assembly includes a disposable drainage tube and a functional tube for providing visualization function, the disposable drainage tube and the functional tube are connected detachable along the axial of the tube body, and the functional tube is provided with a self-destructive part for cutting the disposable drainage tube. A corresponding endoscope is also provided. The visualized surgical assembly is a combination structure of the disposable drainage tube and the functional tube which can provide visualization function. The disposable drainage tube can removable connect with the functional tube, and the functional tube can be repeated disinfection, which can reduce the cost and avoid the risk of cross infection.
    Type: Application
    Filed: May 13, 2019
    Publication date: April 21, 2022
    Applicant: SHANGHAI OUTAI MEDICAL EQUIPMENT CO. LTD.
    Inventors: Rui Xu, Suping Liu, Zhujun Tang, Tong Zhao, Lei Cen, Yungui Liu, Xukai Wang, Qiang Cheng
  • Patent number: 11304911
    Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: April 19, 2022
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Qiang Cheng, Tuo Wei, Daniel J. Siegwart